iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Medplus Health Services Faces Share Dip as Mumbai Store's Drug License Gets Suspended

16 Feb 2024 , 01:19 PM

Medplus Health Services' share price experienced marginal decline early on February 16 following the suspension of a subsidiary's drug license for a Mumbai store. At the time of writing, Medplus Health Services was trading at ₹668.95, marking a 4.99% increase on the BSE.

The Thane Food and Drug Administration imposed a 15-day suspension on the drug license for the Khopat Thane store due to violations of various conditions.

In January, the company faced license suspension orders for six days for a store in Shankarayapally Jadcherla and seven days for a store in Hayath Nagar, both issued by the assistant director and drug sales licensing authority of the Drug Control Administration, Mahabubnagar TS.

In December, one of the subsidiary companies received similar orders from the assistant director and drug sales licensing authority and drug control authorities at various locations.

MedPlus Health Services, headquartered in Hyderabad, is India's second-largest pharmacy chain, operating over 3,000 pharmacy stores across 374 cities as of 2022.

The company offers a range of products, including prescription and OTC medicines, FMCG products, vitamins, nutrition supplements, opticals, clinical laboratory services, and physician consultation services in Hyderabad, Vijayawada, and Bangalore. Additionally, MedPlus owns and operates an ePharmacy and an online clinical lab service.

For feedback and suggestions, write to us at editorial@iifl.com

 

Related Tags

  • Medplus Health Services
  • Mumbai
  • news
  • Thane Food and Drug Administration
sidebar mobile

BLOGS AND PERSONAL FINANCE

Images
15 Apr 2024   |   12:16 PM
Images
15 Apr 2024   |   10:33 AM
Images
15 Apr 2024   |   09:44 AM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

closeIcon

Get better recommendations & make better investments

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp